Helus Pharma, a clinical stage pharmaceutical company developing novel serotonergic agonists (NSAs), has appointed Dr. Ken Kramer, PhD as Senior Vice President, Medical Affairs, effective immediately. Kramer joins Helus with more than two decades of experience leading medical affairs strategy across neuroscience programs, including global launch readiness, evidence generation, and engagement with key opinion leaders. Most recently, he served as Vice President and Head of Medical Neuroscience ...